diltiazem has been researched along with fendiline in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Addicks, K; Fricke, U; Gielen, W; Klaus, W; Sarram, M; Werner, G | 1 |
| Grossmann, M; Lubnau, E; Rück, W; Schulz, J | 1 |
| Fabrègues, E; John, GW; Kamal, M; Massingham, R | 1 |
| Robak, J; Shridi, F | 1 |
| Cartheuser, CF | 1 |
| Duniec, Z; Robak, J | 1 |
| Hütter, JF; Piper, HM; Spieckermann, PG | 1 |
| Baker, JE; Hearse, DJ | 1 |
| Becker, HJ; Dowinsky, S; Hopf, R; Kaltenbach, M; Kober, G | 1 |
| Harmony, JA; Jackson, RJ; Ranganathan, S | 1 |
| Meera, P; Prakash, P; Tripathi, O | 1 |
1 review(s) available for diltiazem and fendiline
| Article | Year |
|---|---|
[Treatment of angina pectoris with calcium antagonists].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Therapy, Combination; Exercise Test; Fendiline; Humans; Nicardipine; Nifedipine; Perhexiline; Prenylamine; Propafenone; Propiophenones; Verapamil | 1982 |
1 trial(s) available for diltiazem and fendiline
| Article | Year |
|---|---|
Double-blind, randomized study of the anti-anginal and anti-ischaemic efficacy of fendiline and diltiazem in patients with coronary heart disease.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Blood Pressure; Diltiazem; Double-Blind Method; Electrocardiography; Exercise Test; Female; Fendiline; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Work | 1991 |
13 other study(ies) available for diltiazem and fendiline
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Sialic acid removal modulates the myocardial and vascular activity of calcium channel ligands.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Calcium; Calcium Channels; Cricetinae; Diltiazem; Dose-Response Relationship, Drug; Electric Stimulation; Fendiline; Gallopamil; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; N-Acetylneuraminic Acid; Neuraminidase; Nisoldipine; Rabbits; Sialic Acids | 1991 |
Caffeine-induced contractions in rabbit isolated renal artery are differentially inhibited by calcium antagonists.
Topics: Animals; Bepridil; Caffeine; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Flunarizine; Kinetics; Lidoflazine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Rabbits; Renal Artery; Verapamil | 1991 |
The influence of calcium channel blockers on superoxide anions.
Topics: Animals; Anions; Calcium Channel Blockers; Diltiazem; Fendiline; Free Radicals; In Vitro Techniques; Microsomes, Liver; Nifedipine; Oxidation-Reduction; Rats; Superoxides; Verapamil; Xanthine Oxidase | 1988 |
Slow channel inhibitor effects on brain function: tolerance to severe hypoxia in the rat.
Topics: Animals; Bencyclane; Bepridil; Brain; Calcium Channel Blockers; Cinnarizine; Diltiazem; Electroencephalography; Fendiline; Flunarizine; Gallopamil; Heart Rate; Hypoxia; Nimodipine; Prenylamine; Pyrrolidines; Rats; Rats, Inbred Strains; Respiration; Verapamil | 1988 |
Membrane activity, antioxidant, antiaggregatory and antihemolytic properties of four calcium channel blockers.
Topics: Animals; Antioxidants; Blood Platelets; Calcium Channel Blockers; Cell Membrane; Diltiazem; Erythrocytes; Fendiline; Hemolysis; In Vitro Techniques; Nifedipine; Platelet Aggregation; Rabbits; Verapamil | 1986 |
Temperature dependence of calcium antagonist action.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Kinetics; Myocardial Contraction; Myocardium; Nifedipine; Rats; Temperature; Verapamil | 1985 |
Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs.
Topics: Animals; Butylamines; Calcium; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Gallopamil; In Vitro Techniques; Ion Channels; Male; Myocardium; Nifedipine; Prenylamine; Rats; Verapamil | 1983 |
Effect of Ca2+ blocking agents on the metabolism of low density lipoproteins in human skin fibroblasts.
Topics: Benzazepines; Calcium Channel Blockers; Dibucaine; Diltiazem; Fendiline; Fibroblasts; Gallopamil; Humans; Kinetics; Lipoproteins, LDL; Nifedipine; Phenethylamines; Prenylamine; Pyridines; Skin; Trifluoperazine; Verapamil | 1982 |
Effects of calcium channel blockers on spontaneous electrical activity of freshly isolated three-day-old embryonic chick ventricle.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Chick Embryo; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Heart Ventricles; In Vitro Techniques; Isoproterenol; Nifedipine; Regression Analysis; Tetrodotoxin; Ventricular Function; Verapamil | 1996 |